Bill Gates Discusses Meeting with Trump Elon Musks Dogecoin and Personal History in WSJ Interview Ahead of Memoir Burberry Shares Surge After Report Suggests Moncler Takeover Interest AeroVironment Enhances AV Halo Platform With Two New Software Additions Michael Saylor Tokenization Could Allow Investors to Shop for Yield Challenging Traditional Banking Jamie Dimon Signals JPMorgan Chase Could Pursue 20 Billion Acquisition Amid Regulatory Scrutiny SpaceX IPO Could Rank Among the Largest Stock Market Debuts in History IMPP Q1 2026 Earnings EPS Surges 64 Above Estimates Stock Declines on Lack of Revenue Disclosure Wetouch Technology Inc WETH Q1 1996 Earnings EPS Misses Estimates as Stock Rises 667 DTIL Q1 2026 Earnings EPS Misses Estimates as Gene Editing Pipeline Progress Takes Center Stage NXT Q1 2026 Earnings EPS Surprises 1316 Above Estimates QuickLogic Q1 2026 Earnings EPS Misses Estimates Amid Revenue Uncertainty Kandal M Venture FMFC Rallies 3 From Support Potential Breakout Above 041 in Sight Energy Focus Inc EFOI Edges Higher on Light Trading Key Levels in Focus Korea Electric Power Corporation KEP Tests Support Zone as Shares Edge Lower TrustCo Bank TRST Edges Lower Amid Consolidation Near Key Support Levels AH Realty Trust AHRT Holds Near Support Amid Broader Real Estate Sector Pressure Geopolitical Frictions Taiwan Arms Sales Emerge as Pivotal Point in TrumpXi Summit ESTC Q1 2026 Earnings EPS Surges Past Estimates Driving Positive Market Reaction WiMi Hologram Cloud Slips Slightly as Stock Hovers Near Key Support Levels EXPE Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Resilient Travel Demand ASUR Q1 2026 Earnings EPS Beats Estimates by 183 as Revenue Details Remain Under Wraps CNH Q1 2026 Earnings EPS Surprises 754 Above Estimate Amid Challenging Environment Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment OLOX Q3 2023 Earnings NarrowerthanExpected Loss Drives 3736 EPS Surprise Core Laboratories Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Market Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4